The letter arrived in our inbox the way most of them do. A 46-year-old patient, active and normal weight by every chart, had watched her HbA1c drift from 5.4 to 5.9 in three years. Her doctor told her to watch it. Nobody had ever drawn a fasting insulin. She wanted to know what insulin resistance treatment actually looks like when someone takes it seriously and whether she was headed for a lifetime of medication. This article is the answer we gave her, in the order we would apply it, because order is the part almost everyone gets wrong.
- Insulin resistance is staged with fasting insulin against fasting glucose and HbA1c, because insulin runs high years before glucose moves.
- Treatment works in sequence: measure, build muscle, anchor protein, repair sleep, then consider medication.
- Muscle is the highest-yield intervention because it is the tissue that disposes of most mealtime glucose.
- Medication including metformin and branded GLP-1s has a real role once staging shows the pancreas straining.
- Every decision is re-tested on labs every 90 days so the plan follows evidence rather than momentum.
Step one: stage it before treating it
Treating insulin resistance without staging it is like driving at night without headlights. The condition exists on a timeline and the treatment differs at each point. Fasting glucose of 98 with a fasting insulin at the top of its range is a very different clinical situation from an HbA1c of 6.2 with a pancreas visibly struggling, even though a standard visit might describe both as borderline.
The staging panel we use is short. HbA1c and fasting glucose place you on the timeline. Fasting insulin shows how hard your pancreas is working to keep those numbers where they are and it is the marker standard panels skip, which is how a decade of rising insulin gets called normal. Triglycerides read against HDL add the cheapest confirming signature of resistance. ApoB and hs-CRP tell us what the same metabolic process is doing to your cardiovascular risk, because it is doing something. Full hormone and thyroid panels close the loop, since thyroid dysfunction and midlife hormone shifts both worsen insulin sensitivity and both are treatable.
This is the reasoning behind our Biomarker Audit running every 90 days. One panel is a snapshot. Four a year are a direction. Treatment decisions belong to the direction.
Step two: build the muscle, because muscle is the treatment
Here is the sentence we wish every patient heard at diagnosis. Muscle is not decoration on top of metabolic health. It is the largest glucose disposal depot in the body and the tissue that takes up most of the glucose from every meal you eat. More responsive muscle means less insulin demanded of a pancreas that has been overworking for years.
The practical prescription is resistance training two to three times per week covering the major movement patterns, with progressive overload. It does not require a gym identity or a perfect program. Two sessions of dumbbell work at home done consistently beat the ideal plan abandoned in February. Patients who resist this step usually have never been told why it matters more than any food rule they have been handed. Once they understand the mechanism the compliance problem mostly solves itself.
Step three: protein and the plate
Muscle cannot be built without protein, so the nutrition instruction follows the training instruction rather than replacing it. The working target is protein at every eating occasion, enough to support the training you have just committed to. Beyond that, the dietary advice for insulin resistance is less exotic than the internet claims. The pattern that moves fasting insulin in our protocols is ordinary food eaten in a structure that reduces visceral fat, which is the fat wrapped around your liver and organs and the strongest driver of hepatic insulin resistance.
Ask for fasting insulin alongside your next HbA1c. It is inexpensive, it is the single most clarifying marker in this condition and it typically rises years before glucose does, which is precisely the head start treatment needs.
Step four: sleep and stress, treated as metabolic variables
Sleep debt is not a lifestyle footnote here. A few consecutive short nights measurably reduce insulin sensitivity and untreated sleep apnea does the same chronically. In the staging conversation we ask about sleep hours, snoring and morning headaches with the same seriousness we ask about family history, because a protocol that fixes muscle while ignoring apnea is a protocol fighting itself. Chronic stress raises glucose through cortisol and deserves the same clinical attention rather than a pamphlet about mindfulness.
Step five: where medication earns its place
We are not a clinic that treats medication as failure or as magic. It is a tool with defined jobs and the staging labs tell us when to reach for it. Metformin has decades of safety data, improves hepatic insulin sensitivity and has a legitimate role in prediabetes as the Diabetes Prevention Program demonstrated. Branded GLP-1 medications improve insulin sensitivity substantially through visceral fat loss and glucose control, as the SURMOUNT-1 trial program showed and newer data keeps extending that record.
What we refuse is the reflex the industry has trained. Medication prescribed before staging is guessing. Medication titrated upward forever on a plan where nobody profits from the climb is a choice our model makes structurally honest. Membership is a flat $299 a month after a first charge of $598 covering the first two months together and medication is billed separately by your pharmacy at cost with zero markup. We make money when you get healthier, not when your dose gets stronger, so when your labs improve on less medicine the protocol says step down rather than hold the line.
Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation licensed to practice in all 50 states, working under GoodLife Health's clinical protocols. All labs run through the Beluga Health lab network and additional testing beyond the quarterly cadence is billed at pass-through cost. Only branded, FDA-approved medication is prescribed: Wegovy, Zepbound, Ozempic, Mounjaro, Wegovy Tablets and Foundayo. Never compounded GLP-1, under any circumstance.
What the sequence looks like over a year
By now the shape should be visible, so here it is as it actually unfolds. Months one through three: staging panel, training habit, protein anchor, sleep repair. Month three audit: fasting insulin and HbA1c read against baseline, medication added only where the trend demands it. Months four through six: the dose question resolved on evidence, which frequently means lower rather than higher. Month six audit: the trend confirmed or the protocol revised. Month nine and twelve: the same discipline, which is how a drifting A1c becomes a stable one and how an overworked pancreas gets its workload reduced rather than chemically masked.
The treatment sequence at a glance
stage and action
| Stage | Primary action | What the 90-day audit decides |
|---|---|---|
| Insulin high, glucose normal | Muscle, protein, sleep | Whether the trend bends without medication |
| Prediabetic range | All of the above plus closer review | Whether metformin or a branded GLP-1 is indicated |
| Established resistance with symptoms | Protocol plus medication where staged | Lowest effective dose and whether it can come down |
| Hormonal driver found | Hormone optimization beside the metabolic work | Whether the hormone track changes the medication need |
Who this is not for
If you want a pill instead of a protocol, we are the wrong clinic and the honest answer to your question is that the pill exists but the sequence above is what makes it work. If your fasting insulin has never been measured and your doctor has told you twice that your labs are fine, the first step costs less than a dinner out and changes the entire conversation. And if you are already on medication that was prescribed without staging, the sequence still applies, because the staging you never had is the reason your dose keeps climbing.
If you want the whole picture read as one system rather than one lane, start with the eligibility assessment. Two minutes, no card. A clinician reviews every application because not everyone is accepted.
FAQ
What is the most effective treatment for insulin resistance? Skeletal muscle. Resistance training two to three times weekly with adequate protein is the highest-yield intervention because muscle disposes of most mealtime glucose. Sleep repair comes next and medication earns its place when staging shows the pancreas straining.
Which lab shows insulin resistance? Fasting insulin paired with fasting glucose is the practical staging pair, with HbA1c placing you on the timeline and the triglyceride to HDL ratio as the cheapest confirming signature. A panel without insulin misses the condition in its most treatable years.
Can insulin resistance be reversed? Often yes, especially when caught while glucose is normal or in the prediabetic band. Reversal is a trend proven on repeated labs, which is why the panel is repeated every 90 days.
Does metformin treat insulin resistance? It improves hepatic insulin sensitivity modestly and has decades of safety data in prediabetes. It is a tool rather than a substitute for the muscle, protein and sleep work that addresses the drivers.
Do GLP-1 medications help? Branded GLP-1s improve insulin sensitivity substantially through weight and visceral fat loss, with trial-proven HbA1c reductions. We prescribe branded, FDA-approved options only and titrate to the lowest effective dose.
How long does reversal take? Insulin sensitivity responds within weeks to muscle and sleep changes while lab trends take one to two quarters to show clearly, which is the pace the quarterly audit is built around.
What does this cost? The membership is a flat $299 a month after a $598 first charge covering the first two months together, including a comprehensive Biomarker Audit every 90 days. Medication is billed separately by your pharmacy at cost with zero markup.
Related Reading
- Why am I prediabetic but not overweight?
- Cardiometabolic optimization: the definitive guide
- Biomarker audits vs standard blood tests
- Cardiometabolic optimization at GoodLife Health
References
- Long-term metformin treatment and insulin sensitivity (Diabetes Prevention Program Research Group). 2002. pubmed.ncbi.nlm.nih.gov/11914137/
- Standards of Care in Diabetes (American Diabetes Association). 2023. diabetesjournals.org/care/article/46/Supplement_1/S36/S148117
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, New England Journal of Medicine). 2022. pubmed.ncbi.nlm.nih.gov/35658024/